# pathway_0045: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0045.txt)

**Task:** `pathway`  
**Author key, unchanged:** **B** — Antibiotic biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MELNGIRRRLATAKEAERHRLLLELIRAAAAEALDRPGPLPLDPGRAFGAQGVRGRAAGRLRERLSEATGLPLPATVVFDYPTPGALAGRLCALLLDEPAGPGGANGQMEAEEPIAIVGMGCRLPGDVRSPEGLWRLVHNGTDAISEFPEDRGWTVQQHPDPDHLGTTVTRHAGFLYDAPDFDAGFFAISPGEAVTIDPQHRLLLETTWKAVEDARIDPTSLRGSRTGVFVGLMYSEYGARIRRVPPGAEGYRVVGSMPSVASGRLAYTFGFEGPAVTVDTACSSSLVAMHLAAQSLRKGECTLAVAGGATVMATPWGYIEFSRQRGLAPDGRCRSFSADAAGSSWSEGVGVLLLERLSDARRHGHRVLAVVRGSAVNQDGASNGLTAPNGPAQQRVIRQALAHAGLTTAEVDAVDAHGAGTRLGDPIEAQALLATYGQGRPAGRPLWLGSLKSNIGHTQAAAGAAGVIKMVMAMRHGVLPRSLHITEPTPHVDWTSGAVELLTEARDWPADGRPRRAAVSSFGVGGTNAHIILEQAAPEPERPHAPEADGEPRPLPWPVSGHGAAGLRAQARRLADFLRAGPAAPDADLAYSLATTRATLTDRAVVVAADRAEAIARLTALAEGDQGPRVARATAVPRDRLAFVFPGQGSQWPGMAAELMSCYPVFRESIKECGRSLAPHTDWSLAKVLRGESGAPTLDRVDVVQPALFAVMVSLAALWRSFGVEPSAVAGHSQGEIAAARVAGALSLEDAARVVALRSRALRVLSGRGGMVSVAAPAGQVLRTLERWGGAVSVAAVNGPRSLVISGDPGALGEALAAFEAEGIRARRIPVDYASHSAQVEEIRDTLLTELSGIRPRPATVPFYSTVSGEPLDTTALDTGYWVRNLRDTVQFDRTVRRLLADGHTTFLEMSPHPVLTPGIQETAEEAGADEVLTVESLRRNEGGPARLLTAVAEAHVHGVAVDWSPAFAPHRSPARRPAVLRLSSGAATGLRTRPRPPPMFTTAGLDGIDHPLLGAAIPLADGGGGTLFTGTLSLATHPWLADHAVADVLVVPGTALVEAALRAGAECTGRAMLEELVLQAPLILPEQGTVRIQLSVGGPDGTGRRALILSSRPEDAGADEPWTRHAEGTLAPGGGHPRQDPGPWPPTGAREIDLDDCYRQLAKTGLHYGPAFQGLKRLWRLADDLCLEAELPDSAGESGRYGLHPALFDAALHAAALAGPSGAEPLTRLPFSWSGVALYTAGATRLRARLSFTGPQSLTLTAMDPLGHPVLSVGTLGMRPVTAEALHRAAGTAGTALLRLEWRRQAPEHPAGPDLTGWAWVGAGAPPAQPPDGRPYRDLAALRAELDAGAAVPPVIVLAEPATPEGTDPFTAARAALHRTLAAIQDWAAEERLAGTRLVVLTQGAVAATPGALPDPALAAVWGLVRSAQAEYPDRIGLVDTDDPGRSRAAVAAAVHAGEAQAAVRDGALLVPRLARVTATDGPGGPAWPADGTVLVTGGLGTLGRLVVRHLVTTHGARRLVILSRSGGDSAEVREFVGELLAQGANVQVVKGDAADPAVLERVLDGIPQEHPLAAVAHLAGALDDGVLAAQTPQRLDRVLRPKAEAAWQLHRLTARARVPLLAFSSLSGVLGPAGQAGYAAANAFVDALVQRRRGTGLPGVSMGWGMWATRSGLTGALSDTDARLIARTGVRPLTDEEGLALFDQARATGEPVVFPLGLDITALNSGAPDGIPPLLRGLTARTPARRAGAAEAPEPAGEDLAARLAATPEAERDALLLGVVRGHIAAVLGYDDPRAVAERRPFSDIGFDSLRALQLRNRLGAATGRRLPATLVFDHPNPAALSRYLRTLLLPDPAPAPTAPDGQPGPDQADQVIERLNSASLEEVLDFIDHQLGE

[Multiple Choices]
A. One-carbon metabolism
B. Antibiotic biosynthesis. .
C. peptidoglycan degradation. .
D. 7,8-dihydrofolate from 2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate and 4-aminobenzoate: step 1/2. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches a UniProt entry whose pathway annotation is “Antibiotic biosynthesis”; the historical entry available by the stated cutoff carries the same annotation. This supports the key as a database annotation, though the excerpts do not independently establish direct experimental validation.

Citations as saved: [H3](#evidence-h3), [C5](#evidence-c5), [H1](#evidence-h1).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The long, multidomain sequence is consistent with a polyketide-synthase-like enzyme, making secondary-metabolite biosynthesis more plausible than one-carbon metabolism, peptidoglycan degradation, or folate synthesis.


**Missing item-specific fact**

> Sequence architecture alone does not establish that this particular polyketide product is an antibiotic; that product/pathway assignment requires protein-specific annotation or other item-specific evidence.


**Reason**

> The sequence offers a useful broad biosynthetic clue, but it does not by itself distinguish antibiotic production from other possible polyketide pathways. The specific assignment needed for B depends on a protein-specific fact absent from the input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the listed choices, B is supported by the matched pathway annotation. The sequence-based clue alone is broader than the antibiotic-specific pathway label.


### Important caveats

- Reviewer-only database evidence was not supplied to the evaluated model.
- The cited database pathway annotation is linked to a publication, but the supplied excerpts do not independently verify the primary experimental evidence.
- The actual author source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The long, multidomain sequence is consistent with a polyketide-synthase-like enzyme, making secondary-metabolite biosynthesis more plausible than one-carbon metabolism, peptidoglycan degradation, or folate synthesis.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "Sequence architecture alone does not establish that this particular polyketide product is an antibiotic; that product/pathway assignment requires protein-specific annotation or other item-specific evidence.",
    "reason": "The sequence offers a useful broad biosynthetic clue, but it does not by itself distinguish antibiotic production from other possible polyketide pathways. The specific assignment needed for B depends on a protein-specific fact absent from the input."
  },
  "case_id": "pathway_0045",
  "expected_answer_check": {
    "evidence_ids": [
      "H3",
      "C5",
      "H1"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt entry whose pathway annotation is “Antibiotic biosynthesis”; the historical entry available by the stated cutoff carries the same annotation. This supports the key as a database annotation, though the excerpts do not independently establish direct experimental validation."
  },
  "important_caveats": [
    "Reviewer-only database evidence was not supplied to the evaluated model.",
    "The cited database pathway annotation is linked to a publication, but the supplied excerpts do not independently verify the primary experimental evidence.",
    "The actual author source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed choices, B is supported by the matched pathway annotation. The sequence-based clue alone is broader than the antibiotic-specific pathway label."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0045",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt entry whose pathway annotation is “Antibiotic biosynthesis”; the historical entry available by the stated cutoff carries the same annotation. This supports the key as a database annotation, though the excerpts do not independently establish direct experimental validation.",
    "evidence_ids": ["H3", "C5", "H1"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The long, multidomain sequence is consistent with a polyketide-synthase-like enzyme, making secondary-metabolite biosynthesis more plausible than one-carbon metabolism, peptidoglycan degradation, or folate synthesis.",
    "missing_item_specific_fact": "Sequence architecture alone does not establish that this particular polyketide product is an antibiotic; that product/pathway assignment requires protein-specific annotation or other item-specific evidence.",
    "reason": "The sequence offers a useful broad biosynthetic clue, but it does not by itself distinguish antibiotic production from other possible polyketide pathways. The specific assignment needed for B depends on a protein-specific fact absent from the input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed choices, B is supported by the matched pathway annotation. The sequence-based clue alone is broader than the antibiotic-specific pathway label."
  },
  "important_caveats": [
    "Reviewer-only database evidence was not supplied to the evaluated model.",
    "The cited database pathway annotation is linked to a publication, but the supplied excerpts do not independently verify the primary experimental evidence.",
    "The actual author source snapshot is unknown."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry B4ER92 (Spectinabilin polyketide synthase system protein NorA, EC 2.3.1.290) explicitly annotates the pathway as 'Antibiotic biosynthesis' with evidence code ECO:0000305 referencing PubMed:17763486 (Traitcheva et al., ChemBioChem 2007). The sequence match is confirmed (SHA-256 identical, 1897 AA). The protein is a modular PKS producing spectinabilin, an antibiotic, in Streptomyces orinoci. The annotation is database-curated (Swiss-Prot) with a literature reference, not merely computational inference.

Citations as saved: [C5](#evidence-c5), [C4](#evidence-c4), [C7](#evidence-c7), [H3](#evidence-h3), [H1](#evidence-h1).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The supplied sequence is ~1897 residues with a multi-domain modular architecture characteristic of polyketide synthases (repeated KS/AT/ACP/TE-like segments visible as conserved motifs such as 'GHSQGE', 'GAGAPPAQ', 'GGMVSVAAP'). Options A (one-carbon metabolism: e.g., methylenetetrahydrofolate reductase, methionine synthase), C (peptidoglycan degradation: lysozymes, amidases), and D (dihydropteroate synthase, ~300 AA) all involve small, single-domain enzymes incompatible with a ~1900 AA modular multi-domain protein. By eliminating these structurally incompatible options and recognizing the PKS-like domain organization (whose products in Actinomycetes are predominantly antibiotics), option B is the only viable choice. This reasoning uses general knowledge of enzyme size, domain architecture, and Streptomyces secondary metabolism without requiring memorization of this specific protein's database entry.


**Missing item-specific fact**

> None strictly required; however, precise identification of individual PKS domain boundaries from raw sequence without tools is challenging. The elimination logic (large modular enzyme ≠ small-molecule metabolic enzymes) provides a sufficient reasoning path among the four choices.


**Reason**

> The answer can be reached by noting the protein's exceptional length and modular domain architecture, then eliminating options A, C, and D which correspond to small single-domain enzymes in unrelated pathways. Recognizing PKS-like motifs and knowing that Streptomyces PKS products are typically antibiotics provides a positive identification of B. This constitutes general biological reasoning, though it requires specialized domain-knowledge of enzyme architecture.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The UniProt entry also lists 'Polyketide biosynthesis' as a pathway, but this is not among the four choices. Among the provided options, only B (Antibiotic biosynthesis) is compatible with a large modular PKS. Options A, C, and D are structurally and functionally incompatible with the sequence.


### Important caveats

- The UniProt annotation evidence code ECO:0000305 indicates inference from a reference (PubMed:17763486), which describes the aureothin/neoaureothin PKS pathways; the spectinabilin assignment relies on homology to those characterized PKS systems.
- The 'Antibiotic biosynthesis' pathway label is a broad UniProt category; the specific product (spectinabilin) is a polyene antibiotic, but the pathway annotation is somewhat coarse.
- The reviewer-only UniProt evidence was not available to the evaluated model; the reasoning assessment considers only what can be inferred from the raw sequence and general biological knowledge.
- Identifying individual PKS catalytic domains (KS, AT, ACP, TE) from a raw 1897-aa sequence without computational tools is difficult in practice, though the overall multi-domain modular architecture is apparent from length and repetitive segment structure.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The supplied sequence is ~1897 residues with a multi-domain modular architecture characteristic of polyketide synthases (repeated KS/AT/ACP/TE-like segments visible as conserved motifs such as 'GHSQGE', 'GAGAPPAQ', 'GGMVSVAAP'). Options A (one-carbon metabolism: e.g., methylenetetrahydrofolate reductase, methionine synthase), C (peptidoglycan degradation: lysozymes, amidases), and D (dihydropteroate synthase, ~300 AA) all involve small, single-domain enzymes incompatible with a ~1900 AA modular multi-domain protein. By eliminating these structurally incompatible options and recognizing the PKS-like domain organization (whose products in Actinomycetes are predominantly antibiotics), option B is the only viable choice. This reasoning uses general knowledge of enzyme size, domain architecture, and Streptomyces secondary metabolism without requiring memorization of this specific protein's database entry.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None strictly required; however, precise identification of individual PKS domain boundaries from raw sequence without tools is challenging. The elimination logic (large modular enzyme ≠ small-molecule metabolic enzymes) provides a sufficient reasoning path among the four choices.",
    "reason": "The answer can be reached by noting the protein's exceptional length and modular domain architecture, then eliminating options A, C, and D which correspond to small single-domain enzymes in unrelated pathways. Recognizing PKS-like motifs and knowing that Streptomyces PKS products are typically antibiotics provides a positive identification of B. This constitutes general biological reasoning, though it requires specialized domain-knowledge of enzyme architecture."
  },
  "case_id": "pathway_0045",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C4",
      "C7",
      "H3",
      "H1"
    ],
    "judgment": "supported",
    "reason": "UniProt entry B4ER92 (Spectinabilin polyketide synthase system protein NorA, EC 2.3.1.290) explicitly annotates the pathway as 'Antibiotic biosynthesis' with evidence code ECO:0000305 referencing PubMed:17763486 (Traitcheva et al., ChemBioChem 2007). The sequence match is confirmed (SHA-256 identical, 1897 AA). The protein is a modular PKS producing spectinabilin, an antibiotic, in Streptomyces orinoci. The annotation is database-curated (Swiss-Prot) with a literature reference, not merely computational inference."
  },
  "important_caveats": [
    "The UniProt annotation evidence code ECO:0000305 indicates inference from a reference (PubMed:17763486), which describes the aureothin/neoaureothin PKS pathways; the spectinabilin assignment relies on homology to those characterized PKS systems.",
    "The 'Antibiotic biosynthesis' pathway label is a broad UniProt category; the specific product (spectinabilin) is a polyene antibiotic, but the pathway annotation is somewhat coarse.",
    "The reviewer-only UniProt evidence was not available to the evaluated model; the reasoning assessment considers only what can be inferred from the raw sequence and general biological knowledge.",
    "Identifying individual PKS catalytic domains (KS, AT, ACP, TE) from a raw 1897-aa sequence without computational tools is difficult in practice, though the overall multi-domain modular architecture is apparent from length and repetitive segment structure."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The UniProt entry also lists 'Polyketide biosynthesis' as a pathway, but this is not among the four choices. Among the provided options, only B (Antibiotic biosynthesis) is compatible with a large modular PKS. Options A, C, and D are structurally and functionally incompatible with the sequence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0045",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry B4ER92 (Spectinabilin polyketide synthase system protein NorA, EC 2.3.1.290) explicitly annotates the pathway as 'Antibiotic biosynthesis' with evidence code ECO:0000305 referencing PubMed:17763486 (Traitcheva et al., ChemBioChem 2007). The sequence match is confirmed (SHA-256 identical, 1897 AA). The protein is a modular PKS producing spectinabilin, an antibiotic, in Streptomyces orinoci. The annotation is database-curated (Swiss-Prot) with a literature reference, not merely computational inference.",
    "evidence_ids": ["C5", "C4", "C7", "H3", "H1"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The supplied sequence is ~1897 residues with a multi-domain modular architecture characteristic of polyketide synthases (repeated KS/AT/ACP/TE-like segments visible as conserved motifs such as 'GHSQGE', 'GAGAPPAQ', 'GGMVSVAAP'). Options A (one-carbon metabolism: e.g., methylenetetrahydrofolate reductase, methionine synthase), C (peptidoglycan degradation: lysozymes, amidases), and D (dihydropteroate synthase, ~300 AA) all involve small, single-domain enzymes incompatible with a ~1900 AA modular multi-domain protein. By eliminating these structurally incompatible options and recognizing the PKS-like domain organization (whose products in Actinomycetes are predominantly antibiotics), option B is the only viable choice. This reasoning uses general knowledge of enzyme size, domain architecture, and Streptomyces secondary metabolism without requiring memorization of this specific protein's database entry.",
    "missing_item_specific_fact": "None strictly required; however, precise identification of individual PKS domain boundaries from raw sequence without tools is challenging. The elimination logic (large modular enzyme ≠ small-molecule metabolic enzymes) provides a sufficient reasoning path among the four choices.",
    "reason": "The answer can be reached by noting the protein's exceptional length and modular domain architecture, then eliminating options A, C, and D which correspond to small single-domain enzymes in unrelated pathways. Recognizing PKS-like motifs and knowing that Streptomyces PKS products are typically antibiotics provides a positive identification of B. This constitutes general biological reasoning, though it requires specialized domain-knowledge of enzyme architecture."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The UniProt entry also lists 'Polyketide biosynthesis' as a pathway, but this is not among the four choices. Among the provided options, only B (Antibiotic biosynthesis) is compatible with a large modular PKS. Options A, C, and D are structurally and functionally incompatible with the sequence."
  },
  "important_caveats": [
    "The UniProt annotation evidence code ECO:0000305 indicates inference from a reference (PubMed:17763486), which describes the aureothin/neoaureothin PKS pathways; the spectinabilin assignment relies on homology to those characterized PKS systems.",
    "The 'Antibiotic biosynthesis' pathway label is a broad UniProt category; the specific product (spectinabilin) is a polyene antibiotic, but the pathway annotation is somewhat coarse.",
    "The reviewer-only UniProt evidence was not available to the evaluated model; the reasoning assessment considers only what can be inferred from the raw sequence and general biological knowledge.",
    "Identifying individual PKS catalytic domains (KS, AT, ACP, TE) from a raw 1897-aa sequence without computational tools is difficult in practice, though the overall multi-domain modular architecture is apparent from length and repetitive segment structure."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record annotates this protein in antibiotic biosynthesis, both in the current record and in a historical record. The annotation cites a publication, though the excerpts alone do not independently establish the experimental basis for that annotation.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 1,897-residue sequence has the scale and repeated catalytic-domain pattern characteristic of a modular polyketide synthase assembly-line protein. Such synthases build specialized polyketide natural products, making antibiotic biosynthesis a meaningful fit among these choices; the other options concern folate metabolism or peptidoglycan degradation and do not fit this large assembly-line architecture.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> Recognizing the transferable modular-PKS pattern provides a credible distinction among the offered alternatives. Sequence-level recognition does not by itself identify the specific product or prove that every polyketide made by such machinery is an antibiotic, but that finer distinction is not needed to favor B over these choices.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The offered alternatives are sufficiently distinct for the modular-polyketide-synthase inference to favor B; no competing option is comparably supported by the sequence.


### Important caveats

- The pathway evidence is a database annotation supported by a cited publication; the supplied excerpts do not independently establish the precise experimental evidence.
- A modular polyketide synthase pattern supports the pathway choice but does not, by itself, establish the identity or therapeutic use of the product.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 1,897-residue sequence has the scale and repeated catalytic-domain pattern characteristic of a modular polyketide synthase assembly-line protein. Such synthases build specialized polyketide natural products, making antibiotic biosynthesis a meaningful fit among these choices; the other options concern folate metabolism or peptidoglycan degradation and do not fit this large assembly-line architecture.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "Recognizing the transferable modular-PKS pattern provides a credible distinction among the offered alternatives. Sequence-level recognition does not by itself identify the specific product or prove that every polyketide made by such machinery is an antibiotic, but that finer distinction is not needed to favor B over these choices."
  },
  "case_id": "pathway_0045",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates this protein in antibiotic biosynthesis, both in the current record and in a historical record. The annotation cites a publication, though the excerpts alone do not independently establish the experimental basis for that annotation."
  },
  "important_caveats": [
    "The pathway evidence is a database annotation supported by a cited publication; the supplied excerpts do not independently establish the precise experimental evidence.",
    "A modular polyketide synthase pattern supports the pathway choice but does not, by itself, establish the identity or therapeutic use of the product."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The offered alternatives are sufficiently distinct for the modular-polyketide-synthase inference to favor B; no competing option is comparably supported by the sequence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0045",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates this protein in antibiotic biosynthesis, both in the current record and in a historical record. The annotation cites a publication, though the excerpts alone do not independently establish the experimental basis for that annotation.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 1,897-residue sequence has the scale and repeated catalytic-domain pattern characteristic of a modular polyketide synthase assembly-line protein. Such synthases build specialized polyketide natural products, making antibiotic biosynthesis a meaningful fit among these choices; the other options concern folate metabolism or peptidoglycan degradation and do not fit this large assembly-line architecture.",
    "missing_item_specific_fact": "",
    "reason": "Recognizing the transferable modular-PKS pattern provides a credible distinction among the offered alternatives. Sequence-level recognition does not by itself identify the specific product or prove that every polyketide made by such machinery is an antibiotic, but that finer distinction is not needed to favor B over these choices."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The offered alternatives are sufficiently distinct for the modular-polyketide-synthase inference to favor B; no competing option is comparably supported by the sequence."
  },
  "important_caveats": [
    "The pathway evidence is a database annotation supported by a cited publication; the supplied excerpts do not independently establish the precise experimental evidence.",
    "A modular polyketide synthase pattern supports the pathway choice but does not, by itself, establish the identity or therapeutic use of the product."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry B4ER92 (Spectinabilin polyketide synthase system protein NorA) is explicitly annotated with PATHWAY: Antibiotic biosynthesis (ECO:0000305|PubMed:17763486). The protein is a modular polyketide synthase (PKS) producing spectinabilin, a polyketide antibiotic. The annotation is based on experimental evidence from the primary publication. Polyketide biosynthesis is also listed, but among the offered choices, 'Antibiotic biosynthesis' is the correct and directly supported answer.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [C4](#evidence-c4), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 1897-amino-acid sequence exhibits the hallmark architecture of a modular Type I polyketide synthase (PKS): multiple catalytic domain motifs arranged in tandem, including AT domain signatures (GHSQGE, GGMVSVAAPAGQ), KR domain NADPH-binding motifs (GGLGTLGRL), and other iterative catalytic elements. This multi-domain modular organization is diagnostic of Type I PKS systems, which are well-known for synthesizing polyketide natural products. A knowledgeable model can (1) recognize the PKS domain architecture from sequence motifs and the extraordinary protein length, (2) recall that modular PKS enzymes are the biosynthetic workhorses for polyketide natural products, (3) know from extensive literature (erythromycin PKS, tetracycline PKS, actinorhodin PKS, etc.) that a large fraction of polyketide products are antibiotics, especially from Actinomycetes. Meanwhile, options A (one-carbon metabolism), C (peptidoglycan degradation), and D (dihydrofolate synthesis) involve small enzymes (typically 200-400 AA) with entirely different catalytic folds (e.g., DHPS is ~250 AA; peptidoglycan hydrolases are lysozyme/amidase folds; one-carbon enzymes are folate-binding or methyltransferase folds). The 1897-AA multi-domain PKS architecture is incompatible with any of these, leaving B as the only viable choice.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> Recognition of modular PKS domain architecture from sequence motifs (AT: GHSxG, KR: GxGxxG, etc.) and the very large protein size is a well-established transferable skill. The association of PKS products with antibiotic biosynthesis is broad, well-documented general knowledge across many characterized PKS systems. The elimination of options A, C, and D follows straightforwardly from their incompatibility with a 1897-AA multi-domain enzyme. No target-specific annotation is needed to make this distinction.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A, C, and D describe pathways involving small, single-domain enzymes (folate-cycle enzymes, peptidoglycan hydrolases, DHPS) that are structurally and functionally incompatible with a 1897-AA modular PKS. Only option B (Antibiotic biosynthesis) is consistent with the PKS architecture. Although UniProt also annotates 'Polyketide biosynthesis,' that option is not offered, so there is no ambiguity among the given choices.


### Important caveats

- The UniProt entry also lists 'Polyketide biosynthesis' as a pathway; this is not among the choices but is a more specific description. The offered answer 'Antibiotic biosynthesis' is the broader UniProt pathway category and is correct among the given options.
- The sequence-based PKS domain recognition relies on motif-level pattern matching; a model without explicit PKS training might miss some motifs, but the overall size and multi-domain architecture remain strongly diagnostic.
- The protein is from Streptomyces orinoci, a genus renowned for antibiotic production, which further supports the antibiotic biosynthesis pathway assignment, though this organism-level inference requires recognizing Actinomycetota/Streptomycetaceae context from sequence composition.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 1897-amino-acid sequence exhibits the hallmark architecture of a modular Type I polyketide synthase (PKS): multiple catalytic domain motifs arranged in tandem, including AT domain signatures (GHSQGE, GGMVSVAAPAGQ), KR domain NADPH-binding motifs (GGLGTLGRL), and other iterative catalytic elements. This multi-domain modular organization is diagnostic of Type I PKS systems, which are well-known for synthesizing polyketide natural products. A knowledgeable model can (1) recognize the PKS domain architecture from sequence motifs and the extraordinary protein length, (2) recall that modular PKS enzymes are the biosynthetic workhorses for polyketide natural products, (3) know from extensive literature (erythromycin PKS, tetracycline PKS, actinorhodin PKS, etc.) that a large fraction of polyketide products are antibiotics, especially from Actinomycetes. Meanwhile, options A (one-carbon metabolism), C (peptidoglycan degradation), and D (dihydrofolate synthesis) involve small enzymes (typically 200-400 AA) with entirely different catalytic folds (e.g., DHPS is ~250 AA; peptidoglycan hydrolases are lysozyme/amidase folds; one-carbon enzymes are folate-binding or methyltransferase folds). The 1897-AA multi-domain PKS architecture is incompatible with any of these, leaving B as the only viable choice.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "Recognition of modular PKS domain architecture from sequence motifs (AT: GHSxG, KR: GxGxxG, etc.) and the very large protein size is a well-established transferable skill. The association of PKS products with antibiotic biosynthesis is broad, well-documented general knowledge across many characterized PKS systems. The elimination of options A, C, and D follows straightforwardly from their incompatibility with a 1897-AA multi-domain enzyme. No target-specific annotation is needed to make this distinction."
  },
  "case_id": "pathway_0045",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "C4",
      "H3",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry B4ER92 (Spectinabilin polyketide synthase system protein NorA) is explicitly annotated with PATHWAY: Antibiotic biosynthesis (ECO:0000305|PubMed:17763486). The protein is a modular polyketide synthase (PKS) producing spectinabilin, a polyketide antibiotic. The annotation is based on experimental evidence from the primary publication. Polyketide biosynthesis is also listed, but among the offered choices, 'Antibiotic biosynthesis' is the correct and directly supported answer."
  },
  "important_caveats": [
    "The UniProt entry also lists 'Polyketide biosynthesis' as a pathway; this is not among the choices but is a more specific description. The offered answer 'Antibiotic biosynthesis' is the broader UniProt pathway category and is correct among the given options.",
    "The sequence-based PKS domain recognition relies on motif-level pattern matching; a model without explicit PKS training might miss some motifs, but the overall size and multi-domain architecture remain strongly diagnostic.",
    "The protein is from Streptomyces orinoci, a genus renowned for antibiotic production, which further supports the antibiotic biosynthesis pathway assignment, though this organism-level inference requires recognizing Actinomycetota/Streptomycetaceae context from sequence composition."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, C, and D describe pathways involving small, single-domain enzymes (folate-cycle enzymes, peptidoglycan hydrolases, DHPS) that are structurally and functionally incompatible with a 1897-AA modular PKS. Only option B (Antibiotic biosynthesis) is consistent with the PKS architecture. Although UniProt also annotates 'Polyketide biosynthesis,' that option is not offered, so there is no ambiguity among the given choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0045",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry B4ER92 (Spectinabilin polyketide synthase system protein NorA) is explicitly annotated with PATHWAY: Antibiotic biosynthesis (ECO:0000305|PubMed:17763486). The protein is a modular polyketide synthase (PKS) producing spectinabilin, a polyketide antibiotic. The annotation is based on experimental evidence from the primary publication. Polyketide biosynthesis is also listed, but among the offered choices, 'Antibiotic biosynthesis' is the correct and directly supported answer.",
    "evidence_ids": ["C5", "C6", "C4", "H3", "H4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 1897-amino-acid sequence exhibits the hallmark architecture of a modular Type I polyketide synthase (PKS): multiple catalytic domain motifs arranged in tandem, including AT domain signatures (GHSQGE, GGMVSVAAPAGQ), KR domain NADPH-binding motifs (GGLGTLGRL), and other iterative catalytic elements. This multi-domain modular organization is diagnostic of Type I PKS systems, which are well-known for synthesizing polyketide natural products. A knowledgeable model can (1) recognize the PKS domain architecture from sequence motifs and the extraordinary protein length, (2) recall that modular PKS enzymes are the biosynthetic workhorses for polyketide natural products, (3) know from extensive literature (erythromycin PKS, tetracycline PKS, actinorhodin PKS, etc.) that a large fraction of polyketide products are antibiotics, especially from Actinomycetes. Meanwhile, options A (one-carbon metabolism), C (peptidoglycan degradation), and D (dihydrofolate synthesis) involve small enzymes (typically 200-400 AA) with entirely different catalytic folds (e.g., DHPS is ~250 AA; peptidoglycan hydrolases are lysozyme/amidase folds; one-carbon enzymes are folate-binding or methyltransferase folds). The 1897-AA multi-domain PKS architecture is incompatible with any of these, leaving B as the only viable choice.",
    "missing_item_specific_fact": "",
    "reason": "Recognition of modular PKS domain architecture from sequence motifs (AT: GHSxG, KR: GxGxxG, etc.) and the very large protein size is a well-established transferable skill. The association of PKS products with antibiotic biosynthesis is broad, well-documented general knowledge across many characterized PKS systems. The elimination of options A, C, and D follows straightforwardly from their incompatibility with a 1897-AA multi-domain enzyme. No target-specific annotation is needed to make this distinction."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A, C, and D describe pathways involving small, single-domain enzymes (folate-cycle enzymes, peptidoglycan hydrolases, DHPS) that are structurally and functionally incompatible with a 1897-AA modular PKS. Only option B (Antibiotic biosynthesis) is consistent with the PKS architecture. Although UniProt also annotates 'Polyketide biosynthesis,' that option is not offered, so there is no ambiguity among the given choices."
  },
  "important_caveats": [
    "The UniProt entry also lists 'Polyketide biosynthesis' as a pathway; this is not among the choices but is a more specific description. The offered answer 'Antibiotic biosynthesis' is the broader UniProt pathway category and is correct among the given options.",
    "The sequence-based PKS domain recognition relies on motif-level pattern matching; a model without explicit PKS training might miss some motifs, but the overall size and multi-domain architecture remain strongly diagnostic.",
    "The protein is from Streptomyces orinoci, a genus renowned for antibiotic production, which further supports the antibiotic biosynthesis pathway assignment, though this organism-level inference requires recognizing Actinomycetota/Streptomycetaceae context from sequence composition."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "B4ER92",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "7a2b43eb4693bca9c8e214b8ce966e5161f55926389724de9065d4baf60d4ff1",
  "benchmark_sequence_length": 1897,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 85,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2008-09-23",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "5eeaeb37c4ffac30774fcace62eb9d316998cb9ebef04f688b171413d879c5c3",
  "current_source_sequence_sha256": "7a2b43eb4693bca9c8e214b8ce966e5161f55926389724de9065d4baf60d4ff1",
  "current_source_sequence_length": 1897,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 83,
  "selected_historical_version": {
    "accession": "B4ER92",
    "database": "Swiss-Prot",
    "entryVersion": 83,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "NORA_STRON",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "3915fd8feae78450aa29f8354771d2a032c0708667b4608cc38f4af415714d8a",
  "selected_historical_source_sequence_sha256": "7a2b43eb4693bca9c8e214b8ce966e5161f55926389724de9065d4baf60d4ff1",
  "selected_historical_source_sequence_length": 1897,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 83,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/B4ER92.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/B4ER92.json",
  "source_sha256": "5eeaeb37c4ffac30774fcace62eb9d316998cb9ebef04f688b171413d879c5c3",
  "retrieved_utc": "2026-11-01T06:25:00.659517+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"B4ER92\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/B4ER92.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/B4ER92.json",
  "source_sha256": "5eeaeb37c4ffac30774fcace62eb9d316998cb9ebef04f688b171413d879c5c3",
  "retrieved_utc": "2026-11-01T06:25:00.659517+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":85,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2008-09-23\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/B4ER92.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/B4ER92.json",
  "source_sha256": "5eeaeb37c4ffac30774fcace62eb9d316998cb9ebef04f688b171413d879c5c3",
  "retrieved_utc": "2026-11-01T06:25:00.659517+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Streptoverticillium orinoci\",\"lineage\":[\"Bacteria\",\"Bacillati\",\"Actinomycetota\",\"Actinomycetes\",\"Kitasatosporales\",\"Streptomycetaceae\",\"Streptomyces\"],\"scientificName\":\"Streptomyces orinoci\",\"taxonId\":67339}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/B4ER92.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/B4ER92.json",
  "source_sha256": "5eeaeb37c4ffac30774fcace62eb9d316998cb9ebef04f688b171413d879c5c3",
  "retrieved_utc": "2026-11-01T06:25:00.659517+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"CAO85893.1\",\"source\":\"EMBL\"}],\"value\":\"Modular polyketide synthase NorA\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"17763486\",\"source\":\"PubMed\"}],\"value\":\"2.3.1.290\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"value\":\"Spectinabilin polyketide synthase system protein NorA\"},\"shortNames\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"value\":\"Spectinabilin PKS system protein NorA\"}]}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/B4ER92.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/B4ER92.json",
  "source_sha256": "5eeaeb37c4ffac30774fcace62eb9d316998cb9ebef04f688b171413d879c5c3",
  "retrieved_utc": "2026-11-01T06:25:00.659517+00:00",
  "json_pointer": "/comments/3",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"17763486\",\"source\":\"PubMed\"}],\"value\":\"Antibiotic biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/B4ER92.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/B4ER92.json",
  "source_sha256": "5eeaeb37c4ffac30774fcace62eb9d316998cb9ebef04f688b171413d879c5c3",
  "retrieved_utc": "2026-11-01T06:25:00.659517+00:00",
  "json_pointer": "/comments/4",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"17763486\",\"source\":\"PubMed\"}],\"value\":\"Polyketide biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/B4ER92.json)

```json
{
  "evidence_id": "C7",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/B4ER92.json",
  "source_sha256": "5eeaeb37c4ffac30774fcace62eb9d316998cb9ebef04f688b171413d879c5c3",
  "retrieved_utc": "2026-11-01T06:25:00.659517+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Traitcheva N.\",\"Jenke-Kodama H.\",\"He J.\",\"Dittmann E.\",\"Hertweck C.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"17763486\"},{\"database\":\"DOI\",\"id\":\"10.1002/cbic.200700309\"}],\"citationType\":\"journal article\",\"firstPage\":\"1841\",\"id\":\"17763486\",\"journal\":\"ChemBioChem\",\"lastPage\":\"1849\",\"publicationDate\":\"2007\",\"title\":\"Non-colinear polyketide biosynthesis in the aureothin and neoaureothin pathways: an evolutionary perspective.\",\"volume\":\"8\"},\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"CAO85893.1\",\"source\":\"EMBL\"}],\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"HKI-0260\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"SUBUNIT\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/B4ER92?format=txt&versions=83)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/B4ER92?format=txt&versions=83",
  "source_sha256": "3915fd8feae78450aa29f8354771d2a032c0708667b4608cc38f4af415714d8a",
  "retrieved_utc": "2026-11-01T06:27:51.676658+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   NORA_STRON              Reviewed;        1897 AA.\nAC   B4ER92;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   23-SEP-2008, sequence version 1.\nDT   28-JAN-2026, entry version 83.\nDE   RecName: Full=Spectinabilin polyketide synthase system protein NorA {ECO:0000305};\nDE            Short=Spectinabilin PKS system protein NorA {ECO:0000305};\nDE            EC=2.3.1.290 {ECO:0000305|PubMed:17763486};\nDE   AltName: Full=Modular polyketide synthase NorA {ECO:0000312|EMBL:CAO85893.1};\nGN   Name=norA {ECO:0000303|PubMed:17763486};\nOS   Streptomyces orinoci (Streptoverticillium orinoci).\nOC   Bacteria; Bacillati; Actinomycetota; Actinomycetes; Kitasatosporales;\nOC   Streptomycetaceae; Streptomyces.\nOX   NCBI_TaxID=67339;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 83,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/B4ER92?format=txt&versions=83)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/B4ER92?format=txt&versions=83",
  "source_sha256": "3915fd8feae78450aa29f8354771d2a032c0708667b4608cc38f4af415714d8a",
  "retrieved_utc": "2026-11-01T06:27:51.676658+00:00",
  "source_locator": "lines 15-22",
  "excerpt": "RN   [1] {ECO:0000312|EMBL:CAO85893.1}\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND SUBUNIT.\nRC   STRAIN=HKI-0260;\nRX   PubMed=17763486; DOI=10.1002/cbic.200700309;\nRA   Traitcheva N., Jenke-Kodama H., He J., Dittmann E., Hertweck C.;\nRT   \"Non-colinear polyketide biosynthesis in the aureothin and neoaureothin\nRT   pathways: an evolutionary perspective.\";\nRL   ChemBioChem 8:1841-1849(2007).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 83,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/B4ER92?format=txt&versions=83)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/B4ER92?format=txt&versions=83",
  "source_sha256": "3915fd8feae78450aa29f8354771d2a032c0708667b4608cc38f4af415714d8a",
  "retrieved_utc": "2026-11-01T06:27:51.676658+00:00",
  "source_locator": "lines 44-44",
  "excerpt": "CC   -!- PATHWAY: Antibiotic biosynthesis. {ECO:0000305|PubMed:17763486}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 83,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/B4ER92?format=txt&versions=83)

```json
{
  "evidence_id": "H4",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/B4ER92?format=txt&versions=83",
  "source_sha256": "3915fd8feae78450aa29f8354771d2a032c0708667b4608cc38f4af415714d8a",
  "retrieved_utc": "2026-11-01T06:27:51.676658+00:00",
  "source_locator": "lines 45-45",
  "excerpt": "CC   -!- PATHWAY: Polyketide biosynthesis. {ECO:0000305|PubMed:17763486}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 83,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 45. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
